AKT1 and breast carcinoma: Xu et al. found that MALAT1 was downregulated in breast tumor cell lines and cancer tissue, and downregulation of MALAT1 in breast cancer cell lines through the activation of phosphatidylinositide-3 kinase-AKT (PI3K-AKT) pathways later results in EMT (58).